Breast cancer drug 'too expensive' for routine use
Health advisors say the drug would have cost more than £90,000 per patient, but some have likened the decision to 'putting a price on life'.
Health advisors say the drug would have cost more than £90,000 per patient, but some have likened the decision to 'putting a price on life'.